著者
Shigeru SENDA Yoshihide FUJIYAMA Tadao BAMBA Shiro HOSODA
出版者
The Japanese Society of Internal Medicine
雑誌
Internal Medicine (ISSN:09182918)
巻号頁・発行日
vol.32, no.4, pp.350-354, 1993 (Released:2006-03-27)
参考文献数
9
被引用文献数
15 20

We were able to induce and maintain remission with camostat mesilate, a serine protease inhibitor, in two patients with ulcerative colitis, to whom salicylazosulfapyridine could not be administered due to previous side effects. The enzymatic activity of proteases from granulocyte, pancreatic juice and bacteria is possibly harmful to the inflammed colonic mucosa. Camostat mesilate can be expected to have an anti-inflammatory effect on the damaged mucosa of inflammatory bowel disease.(Internal Medicine 32: 350-354, 1993)

言及状況

外部データベース (DOI)

Twitter (1 users, 1 posts, 0 favorites)

Increased proteolytic activity precedes colitis. https://t.co/GJWzrY10ZT A protease inhibitor helps reverse colitis. https://t.co/zNvxpJuzL5 Will colonic-coated protease inhibitors be used in the treatment of ulcerative colitis? https://t.co/CyWPeTkVwu

収集済み URL リスト